Schrodinger Revenue 2019-2025 | SDGR

Schrodinger revenue from 2019 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Schrodinger Annual Revenue
(Millions of US $)
2024 $208
2023 $217
2022 $181
2021 $138
2020 $108
2019 $86
2018 $67
Schrodinger Quarterly Revenue
(Millions of US $)
2025-03-31 $60
2024-12-31 $88
2024-09-30 $35
2024-06-30 $47
2024-03-31 $37
2023-12-31 $74
2023-09-30 $43
2023-06-30 $35
2023-03-31 $65
2022-12-31 $57
2022-09-30 $37
2022-06-30 $38
2022-03-31 $49
2021-12-31 $46
2021-09-30 $30
2021-06-30 $30
2021-03-31 $32
2020-12-31 $33
2020-09-30 $26
2020-06-30 $23
2020-03-31 $26
2019-12-31 $26
2019-09-30 $20
2019-06-30 $19
2019-03-31 $21
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.676B $0.208B
Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.108B 58.66
Hims & Hers Health (HIMS) United States $12.792B 132.91
Tempus AI (TEM) United States $12.331B 0.00
IRhythm Technologies (IRTC) United States $4.644B 0.00
Inspire Medical Systems (INSP) United States $3.793B 59.27
Privia Health (PRVA) United States $2.768B 189.17
Hinge Health (HNGE) United States $2.732B 0.00
Enovis (ENOV) United States $1.845B 10.28
Phreesia (PHR) United States $1.584B 0.00
Clover Health Investments (CLOV) United States $1.491B 0.00
Omnicell (OMCL) United States $1.403B 24.74
Azenta (AZTA) United States $1.392B 64.70
10x Genomics (TXG) United States $1.303B 0.00
Fulgent Genetics (FLGT) United States $0.639B 0.00
Claritev (CTEV) United States $0.620B 0.00
Butterfly Network (BFLY) United States $0.603B 0.00
Talkspace (TALK) United States $0.502B 150.00
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.399B 0.00
Outset Medical (OM) United States $0.359B 0.00
TruBridge (TBRG) United States $0.357B 792.33
Health Catalyst (HCAT) United States $0.277B 0.00
Nyxoah SA (NYXH) Belgium $0.258B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.193B 0.00
KORU Medical Systems (KRMD) United States $0.148B 0.00
Pulmonx (LUNG) United States $0.126B 0.00
EUDA Health Holdings (EUDA) Singapore $0.126B 0.00
American Well (AMWL) United States $0.112B 0.00
MDxHealth SA (MDXH) Belgium $0.101B 0.00
CareCloud (CCLD) United States $0.091B 3.48
111 (YI) China $0.071B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Zhongchao (ZCMD) China $0.033B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00